LTBR completed a major equity raise that increased assets by nearly 400% while R&D expenses doubled and operating losses expanded significantly.
The dramatic increase in current assets and stockholders' equity (both up ~400%) indicates a substantial capital raise, likely through equity issuance as evidenced by the 68% increase in outstanding shares from 20.4M to 34.2M. However, this dilutive financing comes amid deteriorating operational performance with doubled R&D spending and significantly wider losses, suggesting the company is in an intensive capital deployment phase for its nuclear fuel development.
LTBR underwent a transformational capital raise that quintupled its balance sheet size with current assets growing from $40.3M to $202.6M, providing substantial financial runway. However, operational performance deteriorated sharply with R&D expenses doubling to $9.2M, operating losses widening 78% to -$23.2M, and operating cash flow declining 50% to -$14.3M. The financial picture reflects a development-stage company that secured significant funding but is now in an intensive cash-burn phase to advance its nuclear fuel technology, creating both opportunity for progress and execution risk given the accelerated spending rate.
Current assets grew 402.5% — improving short-term liquidity or inventory/receivables build.
Equity base grew 400.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Asset base grew 397.7% — expansion through organic growth, acquisitions, or capital deployment.
R&D investment increased 100.3% — signals commitment to future product development, though near-term margin impact.
Current liabilities surged 99.6% — significant near-term obligations; verify ability to meet short-term debt.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Net income declined 66.1% — review whether driven by operations, interest costs, or non-recurring items.
Operating cash flow fell 50.4% — earnings quality concerns; investigate working capital changes and non-cash items.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →